Program Type: ASHP-Accredited PGY2 Oncology
ASHP Match Number: 537860

NOTE: This program offers three resident positions each year, and is recruiting for two resident positions for 2024-2025.

PGY2 Program Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Overview

The Cancer Center

The NCI-designated Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides cancer care services to patients in the Central Maryland and Washington, D.C. areas. For this program, residents will be involved in adult patient care primarily at the Weinberg Building and Viragh Outpatient Building in East Baltimore, with some learning experiences located at Johns Hopkins Bayview Medical Center and Green Spring Station. The oncology pharmacy division within the Weinberg Building provides pharmacy services for over 80 inpatient oncology beds dedicated to Medical Oncology, Hematology and Bone Marrow Transplantation services, an outpatient oncology clinic and urgent care center where over 150 patient visits occur daily, and an Oncology Investigational Drug Service that supports approximately 350 active oncology clinical trials.

Clinical pharmacy specialists and clinical pharmacists provide direct patient care services to patients seen at our Cancer Center, covering oncology specialty areas in the acute care and ambulatory settings, pain and palliative care, pediatric oncology, clinical decision support, and oncology critical care. The residents will interact with numerous clinical pharmacists, pharmacist coordinators, and administrators in the oncology pharmacy division. Direct patient care activities will also involve interaction with physicians, advanced practice providers, nurses, social workers, care coordinators, and other members of the care team. The oncology pharmacy staff participates in therapeutic drug monitoring, provision of drug information, nutrition support, educational in-services, continuing education and patient education.

The Residency Program

The Johns Hopkins Hospital Department of Pharmacy Services has been involved with residency training since the 1940s. Currently, over 30 residents are completing their training at Johns Hopkins. The ASHP-accredited PGY2 oncology residency began in 2000 and now recruits for three residents each year. This 12-month residency provides extensive opportunities for experiential training in both inpatient and ambulatory cancer care, including a community-based practice site.

In addition to daily patient care activities, the resident will have the opportunity to attend multidisciplinary meetings such as oncology grand rounds, disease-specific meetings and case conferences, morbidity and mortality conferences, cancer pain service case conference, and department-supported educational sessions. Residents will complete a medication use evaluation over the course of the year, present an ACPE-accredited Pharmacotherapy Rounds presentation, and will write an article for our departmental newsletter. Graduates of this program will gain real-world problem solving and clinical decision support experience, preparing them to practice independently in a variety of inpatient or ambulatory oncology patient care settings and to successfully achieve BCOP certification.

Please refer to the “Program Overview” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Orientation

The Pharmacy Residency Orientation experience provides a comprehensive and coordinated training program designed to provide incoming residents with an understanding of policies, procedures, and expectations for the pharmacy residency experience. During orientation, residents will participate in hospital, department, and division orientation, and will be exposed to department policies and resources.

Hospital and pharmacy department orientation is required for all new pharmacist hires at Johns Hopkins Hospital. The resident is expected to interact with members of the pharmacy department throughout orientation and to attend assigned orientation and training sessions.

Prior to the start of the residency program, residents will be given a full, detailed orientation itinerary.

Rotations

Required Rotations

• Ambulatory Breast Oncology and Melanoma (1 month)
• Ambulatory Hematologic Malignancies (1 month)
• Ambulatory Thoracic Oncology (1 month)
• Cancer Pain and Palliative Care (1 month)
• Extended Oncology Clinical Decision Support (6 months)
• Extended Oncology Investigational Drug Service (3 months)
• Extended Oncology Pharmacy Practice Management (3 months)
• Inpatient Allogeneic Stem Cell Transplantation (1 month)
• Inpatient Myeloid Malignancies (1 month)
• Inpatient Lymphoid Malignancies (1 month)
• Inpatient Medical Oncology (1 month)
• Longitudinal Weinberg Oncology Pharmacy Staffing (12 months)
• Oncology Formulary Management (3 months)
• PGY2 Oncology Pharmacy Residency Orientation (1 month)

Elective Rotations

• Pediatric Oncology (1 month)
• Transplant and Oncology Adult Infectious Diseases Consult Service (1 month)
• Other elective learning experiences may be developed based on resident interest and preceptor availability

Education Components

• Pharmacotherapy Rounds
  • All residents will provide a 30-minute presentation that is APCE accredited.
  • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.
• Journal Clubs and/or Topic Discussions
  • Residents will participate in the Oncology Weekly Forum. Each resident is expected to prepare and lead approximately nine sessions throughout the year, including two case presentations. Residents will prepare for active participation in preceptor-led discussions on all other scheduled weeks.
  • Residents may also participate in Infectious Diseases and Nutrition topic discussion sessions, as applicable to the care of patients with cancer.
• Teaching Requirements
  • Each Hopkins resident is required to provide educational sessions.
  • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Requirements for Acceptance to the Program

The qualified candidate will have a Doctor of Pharmacy degree from an ACPE accredited school of pharmacy. Prior to the beginning of a PGY2 residency, PGY2 residents must have successfully completed an ASHP-accredited PGY1 pharmacy residency program.

Licensure and Certification Requirements

All residents are expected to obtain a Maryland State Pharmacy License by August 1st.

The resident will arrive at the program already ACLS certified, or will complete certification during the residency year.

Attendance at Professional Meetings

The department will support the resident (expense and leave time) to attend the ASHP Midyear Clinical Meeting, and the HOPA Annual Conference. Any additional travel that is to be supported by the department is evaluated on a case-by-case basis.

Please refer to the “Meetings and Conferences” section of the Department of Pharmacy, Johns Hopkins Medicine website.

MUE Project

The resident must complete a self-directed research or quality improvement project. The scope, magnitude, and type of project will vary according to individual interests but must be completed in a manner suitable for presentation and publication.

Please refer to the “Projects” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Drug Class Review (DCR) or Formulary Management Project

The resident will complete a drug class review as part of the formulary management process. This may be achieved through assisting in the determination of formulary additions/deletions by assessing therapeutic merits, safety, redundancies, and the estimated cost impact on the JHHS.

Committee Participation

The resident will be assigned to departmental, hospital, or health-system committee(s) over the course of the year. The resident will serve in a secretarial role for the Oncology Nurse-Pharmacy Committee, and the Outpatient Oncology Steering and Planning Committee, on a rotating basis.

Staffing Component

Each resident will practice as a pharmacist in a designated area throughout the residency year.

Please refer to the “Staffing Requirements” section of the Department of Pharmacy, Johns Hopkins Medicine

On-Call Coverage

The resident will participate in clinical on-call services. On-call duties include adult and pediatric code response, trauma and stroke calls, administrative assistance, and other duties. On-call hours are from 4 PM to 10 PM on weekdays and 8 AM to 8 PM on weekends and holidays. The frequency of on-call coverage depends upon the number of residents in the entire program and averages about 15 shifts per year.

Please refer to the “On-Call Program” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Paid Time Off (PTO)

Please refer to the “Benefits” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Preceptors

Please refer to the “Preceptors” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Residency Program Coordinator

Carmen N. Janes, PharmD, BCOP
Lead Clinical Pharmacy Specialist, Ambulatory Oncology
Clinical Pharmacy Specialist, Ambulatory Hematologic Malignancies
The Johns Hopkins Hospital
Department of Pharmacy
600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Phone: 443-823-1393
Fax: 410-367-2488
Email: [email protected]

Program Director

Matthew J. Newman, PharmD, MEHP,  BCOP

Title: Clinical Pharmacist Practitoner, Hernatologic Malignancies
Education: Doctor of Pharmacy, Northeastern University;
Master of Education in Health Professions, Johns Hopkins University
Training: Pharmacy Practice Residency - The Johns Hopkins Hospital Oncology Specialty
Residency: The Johns Hopkins Hospital

Dr. Newman is a clinical pharmacist practitioner with the inpatient hematologic malignancies service at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. He is also the Lead Clinical Pharmacy Specialist for Acute Care Oncology at Johns Hopkins and serves as Adjunct Faculty member at Notre Dame of Maryland University.

Dr. Newman has published and presented on topics in oncology pharmacy. He is an active member of the Hematology Oncology Pharmacy Association and serves as a peer reviewer for relevant journals.

Contact

Matthew J. Newman, PharmD, BCOP
Clinical Pharmacist Practitioner, Hematologic Malignancies
Director, PGY2 Oncology Residency
The Johns Hopkins Hospital
600 North Wolfe Street/Carnegie 180
Baltimore, MD 21287
Phone: 410-614-9806
Email: [email protected]